rabeprazole has been researched along with ranitidine in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 23 (82.14) | 29.6817 |
| 2010's | 4 (14.29) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Maekawa, N; Mikawa, K; Nishina, K; Obara, H; Shiga, M; Takao, Y | 1 |
| Breiter, JR; Humphries, TJ; Riff, D | 1 |
| Farley, A; Humphries, TJ; Wruble, LD | 1 |
| Larson, LR; Ofman, JJ; Siddique, RM; Willian, MK; Yamashita, BD | 1 |
| Bardou, M | 1 |
| Caro, JJ; Salas, M; Ward, A | 1 |
| Adachi, K; Kinoshita, Y | 1 |
| Mikawa, K; Morikawa, O; Nishina, K; Obara, H; Takao, Y; Uesugi, T | 1 |
| Adachi, K; Amano, Y; Fujishiro, H; Karim Rumi, MA; Kawamura, A; Kinoshita, Y; Komazawa, Y; Mihara, T; Ono, M; Yuki, M | 1 |
| Furukawa, H; Hata, M; Hattori, T; Iida, M; Negishi, N; Sekino, H; Sezai, A; Sezai, Y; Shiono, M; Soeda, M; Taoka, M; Wakui, S; Yoshitake, I | 1 |
| Han, SY; Jee, SR; Kim, DH; Lee, JT; Park, SJ; Seol, SY; Urm, SH | 1 |
| Baek, JT; Chung, IK; Jeong, HY; Kim, AN; Kim, SH; Kim, SJ; Lee, BS; Lee, DS; Lee, GS; Lee, JM; Lee, SH; Lee, TY; Nam, SW; Oh, JI; Shin, JE; Sung, JK; Yoon, SJ | 1 |
| Furukawa, H; Hata, M; Hattori, T; Iida, M; Negishi, N; Sekino, H; Sezai, A; Sezai, Y; Shiono, M; Taoka, M; Wakui, S; Yoshitake, I | 1 |
| Amano, Y; Ishihara, S; Kinoshita, Y; Kushiyama, Y; Miyake, T; Ose, T; Sato, S; Takahashi, Y; Yuki, T | 1 |
| Esplugues, JV; Martí-Cabrera, M; Ponce, J | 1 |
| Fujiwara, S; Horie, T; Ishikawa, M; Ito, S; Iuchi, A; Okazaki, M; Shimizu, I; Shiraishi, T; Yamamoto, H | 1 |
| Beketov, AS; Belousov, DIu; Belousov, IuB; Karpov, OI | 1 |
| Serebrova, SIu | 1 |
| Mahachai, V; Thong-Ngam, D | 1 |
| Giannoulis, E; Karamanolis, G; Ladas, SD; Theofanidou, I; Triantafyllou, K; Yiasemidou, M | 1 |
| Asaka, M; Imai, A; Kato, M; Ono, S; Ono, Y; Shimizu, Y; Yoshida, T | 1 |
| Aswad, R; El-Samad, S; Haddad, R; Hashash, JG; Jamali, FR; Kobeissy, AA; Ladki, R; Skoury, AM; Soweid, AM | 1 |
| Afzal, NA; Andrews, E; Beattie, RM; Hayen, A; Liddicoat, I; Tighe, MP | 1 |
6 review(s) available for rabeprazole and ranitidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Anti-Ulcer Agents; Benzimidazoles; Child; Child, Preschool; Duodenal Ulcer; Enzyme Inhibitors; Esophagitis, Peptic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Infant; Infant, Newborn; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Stomach Ulcer; Sulfoxides | 2001 |
Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Rabeprazole; Randomized Controlled Trials as Topic; Ranitidine; Sulfoxides; Treatment Outcome | 2001 |
[Cause and prevention of nocturnal gastric acid breakthrough].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Circadian Rhythm; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Esophagitis, Peptic; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Proton Pumps; Rabeprazole; Ranitidine | 2002 |
[Safety of proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Age Factors; Aged; Animals; Anti-Ulcer Agents; Cimetidine; Enzyme Inhibitors; Famotidine; Female; Fetus; Histamine H2 Antagonists; Humans; Lactation; Lansoprazole; Meta-Analysis as Topic; Nizatidine; Omeprazole; Pantoprazole; Pregnancy; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Ranitidine; Safety; Time Factors | 2006 |
Pharmacological treatment of gastro-oesophageal reflux in children.
Topics: Adolescent; Child; Esomeprazole; Gastroesophageal Reflux; Humans; Infant; Infant, Newborn; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine | 2023 |
11 trial(s) available for rabeprazole and ranitidine
| Article | Year |
|---|---|
A comparison of rabeprazole, lansoprazole, and ranitidine for improving preoperative gastric fluid property in adults undergoing elective surgery.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Elective Surgical Procedures; Female; Gastric Juice; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pneumonia, Aspiration; Prospective Studies; Rabeprazole; Ranitidine | 2000 |
Rabeprazole is superior to ranitidine in the management of active duodenal ulcer disease: results of a double-blind, randomized North American study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Duodenoscopy; Female; Humans; Male; Middle Aged; Omeprazole; Pain Measurement; Rabeprazole; Ranitidine; Treatment Outcome | 2000 |
Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Antacids; Benzimidazoles; Double-Blind Method; Female; Gastrins; Gastroesophageal Reflux; Heartburn; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Treatment Outcome | 2000 |
The efficacy of lafutidine in improving preoperative gastric fluid property: a comparison with ranitidine and rabeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Female; Gastric Acid; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Intraoperative Complications; Intubation, Gastrointestinal; Male; Middle Aged; Omeprazole; Piperidines; Preoperative Care; Proton Pump Inhibitors; Pyridines; Rabeprazole; Ranitidine; Risk Assessment; Stomach | 2002 |
Nocturnal gastric acid breakthrough during the administration of rabeprazole and ranitidine in Helicobacter pylori-negative subjects: effects of different regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Chronotherapy; Cross-Over Studies; Drug Therapy, Combination; Gastric Acid; Helicobacter pylori; Humans; Male; Monitoring, Ambulatory; Omeprazole; Rabeprazole; Ranitidine; Reference Values | 2003 |
Prospective randomized trial for optimal prophylactic treatment of the upper gastrointestinal complications after open heart surgery.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cardiac Surgical Procedures; Diterpenes; Endoscopy, Gastrointestinal; Gastritis; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Incidence; Omeprazole; Postoperative Complications; Premedication; Proton-Translocating ATPases; Rabeprazole; Ranitidine; Ulcer; Upper Gastrointestinal Tract | 2005 |
[A randomized, comparative study of rabeprazole vs. ranitidine maintenance therapies for reflux esophagitis--multicenter study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Rabeprazole; Ranitidine | 2005 |
[A randomized, prospective, comparative, multicenter study of rabeprazole and ranitidine in the treatment of reflux esophagitis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Esophagitis, Peptic; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Ranitidine | 2006 |
A glass of water immediately increases gastric pH in healthy subjects.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Antacids; Anti-Ulcer Agents; Cross-Over Studies; Esomeprazole; Female; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Stomach; Time Factors; Water | 2008 |
Immediate acid-suppressing effects of ranitidine hydrochloride and rabeprazole sodium following initial administration and reintroduction: A randomized, cross-over study using wireless pH monitoring capsules.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Cross-Over Studies; Drug Administration Schedule; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Histamine H2 Antagonists; Humans; Male; Monitoring, Ambulatory; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Telemetry; Time Factors | 2009 |
A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Female; Gastroesophageal Reflux; Heartburn; Histamine H2 Antagonists; Humans; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Quality of Life; Rabeprazole; Ranitidine; Treatment Outcome | 2012 |
11 other study(ies) available for rabeprazole and ranitidine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Cost effectiveness of rabeprazole versus generic ranitidine for symptom resolution in patients with erosive esophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cost-Benefit Analysis; Decision Trees; Drug Costs; Drugs, Generic; Enzyme Inhibitors; Esophagitis, Peptic; Gastroesophageal Reflux; Health Care Costs; Histamine H2 Antagonists; Humans; Managed Care Programs; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine; United States | 2000 |
Efficacy of a proton pump inhibitor given in the early postoperative period to relieve symptoms of hiatal hernia after open heart surgery.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Benzimidazoles; Cardiac Surgical Procedures; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastroesophageal Reflux; Gastrointestinal Hemorrhage; Hernia, Hiatal; Humans; Male; Middle Aged; Omeprazole; Patient Satisfaction; Postoperative Care; Probability; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Risk Assessment; Treatment Outcome | 2006 |
Influence of acid suppressants on gastric emptying: cross-over analysis in healthy volunteers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Breath Tests; Cross-Over Studies; Domperidone; Dopamine Antagonists; Famotidine; Gastric Emptying; Humans; Male; Middle Aged; Rabeprazole; Ranitidine; Statistics, Nonparametric | 2006 |
Gastric mucosal levels of prostaglandins and leukotrienes in patients with gastric ulcer after treatment with rabeprazole in comparison to treatment with ranitidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; 6-Ketoprostaglandin F1 alpha; Adult; Aged; Cyclooxygenase 2; Dinoprostone; Female; Gastric Mucosa; Humans; Leukotriene B4; Male; Middle Aged; Rabeprazole; Ranitidine; RNA, Messenger; Stomach Ulcer | 2007 |
[Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Ulcer Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Famotidine; Health Care Costs; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Organometallic Compounds; Peptic Ulcer; Rabeprazole; Ranitidine; Russia | 2007 |
[The clinical effectiveness of rabeprazole in patients with acid-related gastric and duodenal diseases with various sensitivity of different types of parietal gastric cell receptors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Female; Gastric Acid; Gastric Acidity Determination; Gastritis; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Muscarinic Antagonists; Omeprazole; Parietal Cells, Gastric; Pirenzepine; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Receptors, Histamine H2; Receptors, Muscarinic | 2007 |
14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Chi-Square Distribution; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Rabeprazole; Ranitidine; Tetracycline; Treatment Failure | 2006 |